📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Xenios

1.1 - Company Overview

Xenios Logo

Xenios

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of extracorporeal therapy systems delivering minimally invasive disposable lung and heart therapies on a single platform, including the Xenios Console for ECLS in heart and lung failure; MultiSupport GROUND for ground transport requiring extracorporeal gas exchange or circulatory support; Novalung Kits with integrated pressure sensors for blood gas exchange; and iLA activve Kits for gas exchange and temperature control.

Products and services

  • Xenios Console: A single-platform, multifunctional ECLS system that delivers extracorporeal treatment options for heart and lung failure, enabling minimally invasive disposable lung and heart therapies as offered by XENiOS AG
  • ILA activve Kits: Gas-permeable-membrane systems that facilitate extracorporeal blood gas exchange and temperature control, supporting oxygenation and carbon dioxide removal
  • Novalung Kits: Pump-driven devices enabling extracorporeal blood gas exchange of carbon dioxide and oxygen, with integrated pressure sensors for monitoring

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Xenios

Evalve Logo

Evalve

HQ: United States Website
  • Description: Provider of devices enabling repair of cardiac valves, including a non-surgical mitral valve repair system comprising a steerable guide catheter, a clip delivery system, and an implant device used by interventional cardiologists to reduce mitral regurgitation; engaged in the design, development, manufacture, and marketing of these devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evalve company profile →
Lamed Logo

Lamed

HQ: Germany Website
  • Description: Provider of a vascular and cardiovascular product market access platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lamed company profile →
DeVoro Medical Logo

DeVoro Medical

HQ: United States Website
  • Description: Provider of thrombectomy medical devices to restore blood flow, including the WOLF Thrombectomy Platform that captures and removes blood clots from the arterial and venous systems using finger-like prongs, without the need for a console or lytic agents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DeVoro Medical company profile →
WR Medical Logo

WR Medical

HQ: United States Website
  • Description: Provider of medical devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WR Medical company profile →
Cordis Logo

Cordis

HQ: United States Website
  • Description: Provider of less invasive treatments for vascular disease as a Johnson & Johnson company, and developer/manufacturer of stents, catheters, and guidewires. Offerings include SELUTION SLR Drug-Eluting Balloon for controlled, sustained sirolimus release; BRITE TIP Guiding Catheter; MYNX CONTROL Vascular Closure Device; RAIN Sheath Transradial thin-walled introducer; and RAILWAY Sheathless Access System.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cordis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Xenios

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Xenios

2.2 - Growth funds investing in similar companies to Xenios

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Xenios

4.2 - Public trading comparable groups for Xenios

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Xenios

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Xenios

What does Xenios do?

Xenios is a provider of extracorporeal therapy systems delivering minimally invasive disposable lung and heart therapies on a single platform, including the Xenios Console for ECLS in heart and lung failure; MultiSupport GROUND for ground transport requiring extracorporeal gas exchange or circulatory support; Novalung Kits with integrated pressure sensors for blood gas exchange; and iLA activve Kits for gas exchange and temperature control.

Who are Xenios's competitors?

Xenios's competitors and similar companies include Evalve, Lamed, DeVoro Medical, WR Medical, and Cordis.

Where is Xenios headquartered?

Xenios is headquartered in Germany.

How many employees does Xenios have?

Xenios has 1,000 employees 🔒.

When was Xenios founded?

Xenios was founded in 2010 🔒.

What sector and industry vertical is Xenios in?

Xenios is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Xenios

Who are the top strategic acquirers in Xenios's sector and industry

Top strategic M&A buyers and acquirers in Xenios's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Xenios?

Top strategic M&A buyers groups and sectors for Xenios include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Xenios's sector and industry vertical

Which are the top PE firms investing in Xenios's sector and industry vertical?

Top PE firms investing in Xenios's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Xenios's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Xenios's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Xenios's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Xenios include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Xenios's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Xenios?

The key public trading comparables and valuation benchmarks for Xenios include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Xenios for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Xenios with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Xenios's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Xenios with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Xenios's' sector and industry vertical?

Access recent funding rounds and capital raises in Xenios's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Xenios